The North America bone morphogenetic protein market is witnessing steady growth, driven by increasing orthopedic procedures, rising demand for bone graft substitutes, and advancements in regenerative medicine. The region's well-developed healthcare infrastructure and growing adoption of biologic therapies for spinal and orthopedic applications are supporting market expansion. Increasing focus...